These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27259756)

  • 21. Congenital myasthenic syndrome: a brief review.
    Lorenzoni PJ; Scola RH; Kay CS; Werneck LC
    Pediatr Neurol; 2012 Mar; 46(3):141-8. PubMed ID: 22353287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and genetic characterisation of a large Indian congenital myasthenic syndrome cohort.
    Polavarapu K; Sunitha B; Töpf A; Preethish-Kumar V; Thompson R; Vengalil S; Nashi S; Bardhan M; Sanka SB; Huddar A; Unnikrishnan G; Arunachal G; Girija MS; Porter A; Azuma Y; Lorenzoni PJ; Baskar D; Anjanappa RM; Keertipriya M; Padmanabh H; Harikrishna GV; Laurie S; Matalonga L; Horvath R; Nalini A; Lochmüller H
    Brain; 2024 Jan; 147(1):281-296. PubMed ID: 37721175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital myasthenic syndromes: where do we go from here?
    Ramdas S; Beeson D
    Neuromuscul Disord; 2021 Oct; 31(10):943-954. PubMed ID: 34736634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel SEA and LG2 Agrin mutations causing congenital Myasthenic syndrome.
    Xi J; Yan C; Liu WW; Qiao K; Lin J; Tian X; Wu H; Lu J; Wong LJ; Beeson D; Zhao C
    Orphanet J Rare Dis; 2017 Dec; 12(1):182. PubMed ID: 29258548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dok-7 mutations underlie a neuromuscular junction synaptopathy.
    Beeson D; Higuchi O; Palace J; Cossins J; Spearman H; Maxwell S; Newsom-Davis J; Burke G; Fawcett P; Motomura M; Müller JS; Lochmüller H; Slater C; Vincent A; Yamanashi Y
    Science; 2006 Sep; 313(5795):1975-8. PubMed ID: 16917026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variants in SLC18A3, vesicular acetylcholine transporter, cause congenital myasthenic syndrome.
    O'Grady GL; Verschuuren C; Yuen M; Webster R; Menezes M; Fock JM; Pride N; Best HA; Benavides Damm T; Turner C; Lek M; Engel AG; North KN; Clarke NF; MacArthur DG; Kamsteeg EJ; Cooper ST
    Neurology; 2016 Oct; 87(14):1442-1448. PubMed ID: 27590285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.
    Belaya K; Rodríguez Cruz PM; Liu WW; Maxwell S; McGowan S; Farrugia ME; Petty R; Walls TJ; Sedghi M; Basiri K; Yue WW; Sarkozy A; Bertoli M; Pitt M; Kennett R; Schaefer A; Bushby K; Parton M; Lochmüller H; Palace J; Muntoni F; Beeson D
    Brain; 2015 Sep; 138(Pt 9):2493-504. PubMed ID: 26133662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The congenital myasthenic syndromes.
    Palace J; Beeson D
    J Neuroimmunol; 2008 Sep; 201-202():2-5. PubMed ID: 18708269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congenital myasthenic syndromes.
    Beeson D
    Handb Clin Neurol; 2024; 203():69-88. PubMed ID: 39174255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital myasthenic syndrome: phenotypic variability in patients harbouring p.T159P mutation in
    Ardissone A; Moroni I; Bernasconi P; Brugnoni R
    Acta Myol; 2017 Mar; 36(1):28-32. PubMed ID: 28690392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Missense Variant in the AGRN Gene; Congenital Myasthenic Syndrome Presenting With Head Drop.
    Karakaya M; Ceyhan-Birsoy O; Beggs AH; Topaloglu H
    J Clin Neuromuscul Dis; 2017 Mar; 18(3):147-151. PubMed ID: 28221305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromes.
    Müller JS; Jepson CD; Laval SH; Bushby K; Straub V; Lochmüller H
    Hum Mol Genet; 2010 May; 19(9):1726-40. PubMed ID: 20147321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment.
    Webster RG; Cossins J; Lashley D; Maxwell S; Liu WW; Wickens JR; Martinez-Martinez P; de Baets M; Beeson D
    Exp Neurol; 2013 Oct; 248():286-98. PubMed ID: 23797154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localization.
    Wang H; Salter CG; Refai O; Hardy H; Barwick KES; Akpulat U; Kvarnung M; Chioza BA; Harlalka G; Taylan F; Sejersen T; Wright J; Zimmerman HH; Karakaya M; Stüve B; Weis J; Schara U; Russell MA; Abdul-Rahman OA; Chilton J; Blakely RD; Baple EL; Cirak S; Crosby AH
    Brain; 2017 Nov; 140(11):2838-2850. PubMed ID: 29088354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic diversity underlying fast channel congenital myasthenic syndromes.
    Sine SM; Wang HL; Ohno K; Shen XM; Lee WY; Engel AG
    Ann N Y Acad Sci; 2003 Sep; 998():128-37. PubMed ID: 14592870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic Apnea.
    Bauché S; O'Regan S; Azuma Y; Laffargue F; McMacken G; Sternberg D; Brochier G; Buon C; Bouzidi N; Topf A; Lacène E; Remerand G; Beaufrere AM; Pebrel-Richard C; Thevenon J; El Chehadeh-Djebbar S; Faivre L; Duffourd Y; Ricci F; Mongini T; Fiorillo C; Astrea G; Burloiu CM; Butoianu N; Sandu C; Servais L; Bonne G; Nelson I; Desguerre I; Nougues MC; Bœuf B; Romero N; Laporte J; Boland A; Lechner D; Deleuze JF; Fontaine B; Strochlic L; Lochmuller H; Eymard B; Mayer M; Nicole S
    Am J Hum Genet; 2016 Sep; 99(3):753-761. PubMed ID: 27569547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Missense Mutation in Epsilon-subunit of Acetylcholine Receptor Causing Autosomal Dominant Slow-channel Congenital Myasthenic Syndrome in a Chinese Family.
    Tan JZ; Man Y; Xiao F
    Chin Med J (Engl); 2016 Nov; 129(21):2596-2602. PubMed ID: 27779167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in contactin-1, a neural adhesion and neuromuscular junction protein, cause a familial form of lethal congenital myopathy.
    Compton AG; Albrecht DE; Seto JT; Cooper ST; Ilkovski B; Jones KJ; Challis D; Mowat D; Ranscht B; Bahlo M; Froehner SC; North KN
    Am J Hum Genet; 2008 Dec; 83(6):714-24. PubMed ID: 19026398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.
    Rodríguez Cruz PM; Palace J; Beeson D
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital myasthenic syndromes.
    Harper CM
    Semin Neurol; 2004 Mar; 24(1):111-23. PubMed ID: 15229798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.